Shubham Pant

Jeffrey R. Infante

• Sarah Cannon Research Institute
• Sol Goldman Pancreatic Cancer Research Center
• Tennessee Oncology
• Tennessee Oncology PLLC
• Wayne State University
• SCRI
• PLLC/SCRI
• SCRI, Tennessee Oncology, PLLC
• Tennessee Oncology
• Department of Surgery
• Department of Pathology
• Drug Development Program
• GI Oncology Research
• Sarah Cannon Research Institute
• Janssen Inc
• Janssen Pharmaceuticals
• Sarah Canon Research Institute
• Tennessee Oncology PLLC
• Johnson & Johnson

External person

Johanna C. Bendell

• Sarah Cannon Research Institute
• Tennessee Oncology
• GI Oncology Research
• SCRI
• Drug Development Program
• Duke University
• Department of Pathology
• Tennessee Oncology PLLC
• SCRI, Tennessee Oncology, PLLC
• Department of Pathology
• Sarah Cannon Research Institute
• Sarah Cannon
• Tennessee Oncology PLLC
• F. Hoffmann-La Roche AG

External person

Manish R. Patel

• Sarah Cannon Research Institute
• Sarah Cannon Research Institute
• Florida Cancer Specialists
• University of Minnesota Twin Cities
• Medical College of Wisconsin
• Ohio State University
• Sarah Cannon Research Institute

External person

Gerald S. Falchook

• University of Texas MD Anderson Cancer Center
• University of Texas, M.D. Anderson Cancer Center
• Department of Investigational Cancer Therapeutics, University of Texas, MD Anderson Cancer Center
• Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center
• Department of Investigational Cancer Therapeutics, University of Texas MDAnderson Cancer Center
• Clinical Trials Program
• The University of Texas MD Anderson Cancer Center
• Baylor College of Medicine
• University of Texas at Austin
• Department of Investigational Cancer Therapeutics
• Unit 455
• University of Texas M.D. Anderson Cancer Center
• The University of Texas M. D. Anderson Cancer Center
• Sarah Cannon Research Institute at Healthone
• The University of Texas M.D. Anderson Cancer Center
• Sarah Cannon Research Institute at HealthONE, Presbyterian/St. Luke's Medical Center
• Institute at HealthONE
• Sarah Cannon Research Institute at Health ONE, Presbyterian/St. Luke's Medical Center
• Sarah Cannon Research Institute
• FC8.2018
• FC8.2057
• U.T. MD Anderson Cancer Center
• University of Texas MD Anderson Cancer Center
• Houston Clinical Trials
• HealthOne
• Presbyterian-St. Luke's Medical Center
• Sarah Cannon Research Institute
• Unit 455
• University of California at San Diego
• University of Texas MD Anderson Cancer Center
• Department of Investigational Cancer Therapeutics (Phase I Program)
• Sarah Cannon Research Institute at HealthONE
• Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
• Sarah Cannon Research
• Center for Personalized Cancer Therapy and Division of Hematology and Oncology
• Department of Investigational Cancer Therapeutics-a Phase I
• Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program)
• Drug Development Program
• Drug Development Unit
• HealthOne
• Sarah Cannon Research Institute
• Drug Development Program
• University of Texas Health Science Center at Houston

External person

Todd M. Bauer

• Sarah Cannon Research Institute
• Tennessee Oncology
• Sarah Cannon Research Institute
• Tennessee Oncology PLLC
• Department of Drug Development
• Sarah Cannon Research Institute
• PLLC
• Division of Medical Oncology

External person

Carla D. Kurkjian

• Sarah Cannon Research Institute
• University of Oklahoma
• Stephenson Cancer Center/Sarah Cannon Research Institute
• Sarah Cannon Research Institute
• Department of Medicine
• Stephenson Cancer Center
• Sarah Cannon Research Institute

External person

Tanios Bekaii-Saab

• Ohio State University
• Comprehensive Cancer Center and Department of Surgery, The Ohio State University College of Medicine
• The Ohio State University
• Mayo Clinic Scottsdale, AZ
• University of Texas MD Anderson Cancer Center
• Comprehensive Cancer Center
• James Cancer Hospital
• Arthur G. James Cancer Hospital
• Department of Medicine
• Department of Internal Medicine
• Department of Medicine and Pharmacology
• James Cancer Hospital and Solove Research Institute
• Department of Internal Medicine
• Division of Hematology and Medical Oncology
• Division of Medical Oncology
• Department of Medicine
• Department of Internal Medicine
• Department of Medical Oncology
• Depaartment of Medicine
• Department of Pharmacology
• Department of Medicine
• Department of Medical Oncology
• Department of Surgery
• Erasmus University Rotterdam
• Division of Hematology/Oncology
• Mayo Clinic Jacksonville, FL
• Department of Internal Medicine
• Mayo Clinic Rochester, MN
• Mayo Clinic College of Medicine and Science

External person

Kyriakos P. Papadopoulos

• START Center for Cancer Care
• Center for Cancer Care
• South Texas Accelerated Research Therapeutics (START)
• University of South Florida
• South Texas Accelerated Research Therapeutics
• South Texas Accelerated Research Therapeutics
• Astellas Pharma Inc.
• Clinical Research
• South Texas Accelerated Research Therapeutics
• Vanderbilt University
• Institute for Drug Development
• University of Texas Health Science Center at San Antonio
• START
• Clinical Research
• South Texas Accelerated Research Therapeutics
• Hematology/Oncology

External person

Karen A. Autio

• Oregon Health and Science University
• Memorial Sloan-Kettering Cancer Center
• Weil Cornell Medical College
• Cornell University
• Genitourinary Oncology Service
• Department of Medicine

External person

Jonathan D. Mizrahi

• University of Texas MD Anderson Cancer Center
• University of Washington

External person

Martin Oft

• ARMO BioSciences
• Eli Lilly
• ARMO BioSciences
• Synthkine
• Pre-Clinical and Clinical Development
• a wholly owned subsidiary of Eli Lilly and Company

External person

Suzanne F. Jones

• Sarah Cannon Research Institute
• Sarah Cannon Cancer Center
• Novartis
• SCRI
• SCRI, Tennessee Oncology, PLLC
• University of Oxford
• Drug Development Program
• Sarah Cannon Research Institute
• Royal Marsden Hospital, Sutton

External person

Howard Burris

• Sarah Cannon Research Institute
• Sarah Cannon Cancer Center
• Drug Metabolism and Pharmacokinetics
• Novartis
• The University of Texas M.D. Anderson Cancer Center
• University of Texas MD Anderson Cancer Center
• Bristol-Myers Squibb
• Tennessee Oncology
• Tennessee Oncology PLLC
• SCRI
• VA Medical Center
• Sanofi-Aventis
• South Texas Veterans Health Care System
• Department of Drug Development
• Drug Metabolism and Pharmacokinetics Department
• Department of Oncology
• Department of Medical Oncology
• PLLC
• GI Oncology Research
• PLLC
• Sarah Cannon Research Institute
• Drug Development
• Sarah Cannon
• Tennessee Oncology PLLC
• Royal Marsden Hospital, Sutton

External person

Annie Hung

• ARMO BioSciences
• Eli Lilly
• ARMO BioSciences
• Biostatistics

External person

Jing Gong

• University of Texas Health Science Center at Houston
• Huazhong University of Science and Technology
• Department of Biochemistry and Molecular Biology
• Department of Epidemiology and Biostatistics
• MOE Key Laboratory of Bioinformatics
• Tsinghua University
• Center for Synthetic and Systems Biology
• Tsinghua-Peking Center for Life Sciences
• Department of Epidemiology and Biostatistics
• University of Texas MD Anderson Cancer Center
• Department of Investigational Cancer Therapeutics (Phase I Program)
• Huazhong Agricultural University

External person

Deborah J L Wong

• University of California at Los Angeles
• Division of Hematology and Oncology

External person

Jane E. Rogers

• University of Texas M.D. Anderson Cancer Center
• The University of Texas M.D. Anderson Cancer Center
• U.T.M.D. Anderson Cancer Center
• University of Texas MD Anderson Cancer Center
• Departments of Pharmacy Clinical Programs
• Departments of Pharmacy
• Pharmacy Clinical Programs
• Department of Pharmacy Clinical Programs
• Department of Clinical Pharmacy
• Department of Gastrointestinal Medical Oncology
• Department of Clinical Pharmacy Services
• Department of Pharmacy
• Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
• Clinical Pharmacy Section
• University of Texas Health Science Center at Houston
• U.T. M.D. Anderson Cancer Center Pharmacy Clinical Programs

External person

Hung Le

• University of Texas MD Anderson Cancer Center
• Biostatistics
• Guy's and St.Thomas Hospital
• University of Texas Health Science Center at Houston

External person

Zev A. Wainberg

• University of California at Los Angeles
• Division of Hematology/Oncology
• Department of Radiation Oncology
• Department of Radiation Oncology
• Department of Radiation Oncology
• University of Texas MD Anderson Cancer Center

External person

Abdulrazzak Zarifa

• University of Texas MD Anderson Cancer Center
• Brookdale University Hospital and Medical Center

External person

Philippe A. Cassier

• Centre Léon Bérard
• Royal Marsden NHS Foundation Trust
• Département de Médecine
• Drug Development Unit
• Department of Medical Oncology

External person

Eileen M. O'Reilly

• University of Iowa Hospitals and Clinics
• Memorial Sloan-Kettering Cancer Center
• Mem. Sloan Kettering Cancer Center
• Memorial Sloan Kettering Cancer Center
• Memorial Sloan-Kettering Can. Center
• University of Iowa
• Cornell University
• Department of Medicine
• David Rubenstein Pancreatic Cancer Research Center
• Department of Medical Oncology
• Division of Gynecologic Oncology
• Department of Medicine
• Medical Oncology
• Clinical Genetics Service
• Solid Tumor Division
• Gastrointestinal Oncology Service
• David M. Rubenstein Center for Pancreatic Cancer Research
• Division of Solid Tumor Oncology

External person

Rishi Surana

• University of Texas MD Anderson Cancer Center
• Dana-Farber Cancer Institute

External person

Kathleen M. Moore

• University of Oklahoma
• Sarah Cannon Research Institute
• GOG
• Department of Obstetrics and Gynecology
• Department of Obstetrics and Gynecology
• Sarah Cannon Research Institute
• Stephenson Cancer Center
• Stephenson Cancer Center
• Stephenson Cancer Center/Sarah Cannon Research Institute
• Stephenson Oklahoma Cancer Center
• Department of OB/GYN
• Department of Gynecologic Oncology
• Section of Gynecologic Oncology
• Sarah Cannon Research Institute
• Stephenson Cancer Center
• Stephenson Cancer Center

External person

Joseph Leveque

• Amgen Inc.
• Amgen Incorporated
• ARMO BioSciencesRedwood City
• ARMO BioSciences
• Eli Lilly
• ARMO BioSciences
• Scientific Affairs
• Scientific Affiars
• University of California at Los Angeles
• a Sanofi Company

External person

Christophe Massard

• Bristol-Myers Squibb
• Institut Gustave Roussy
• Seattle Cancer Care Alliance
• Cedars-Sinai Medical Center
• Johns Hopkins University
• Centre régional de lutte du cancer Val d'Aurelle
• Fox Chase Cancer Center
• The University of Chicago
• San Camillo Fortanini Hospital
• University of Wisconsin-Madison
• Institute of Cancer Research
• Royal Marsden NHS Foundation Trust
• Drug Development Department
• Department of Medical Oncology
• Department of Oncology
• Division of Oncology
• Department of Oncology
• Section of Hematology/Oncology and Urology and Urology
• Institut Gustave Roussy
• Department of Medical Oncology
• Drug Development Unit
• Division of Clinical Studies
• Drug Development Department (DITEP)
• Drug Development Unit
• University of Washington
• Oncology Department
• Université Paris-Sud
• Department of Cancer Medicine
• Department of Medical Oncology
• Drug Development Unit
• Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP)
• Department of Cancer Medicine
• ComUE Paris-Saclay
• Drug Development Department (DITEP)
• Departments of Drug Development (DITEP
• Department of Cancer Medicine
• Institut national de la santé et de la recherche médicale
• Département d'Innovation Thérapeutique et d'Essais Précoces
• Gustave Roussy
• Department of Medical Oncology
• Université Paris-Saclay
• Cancer Medicine
• Department of Oncology
• Drug Development Department
• The Institute of Cancer Research, London
• DITEP
• Institut Gus-tave Roussy
• Universite Paris Saclay

External person

Erick Campbell

• University of Texas MD Anderson Cancer Center
• University of Texas Health Science Center at Houston

External person

P. Van Vlasselaer

• Dendreon
• Stanford University
• Activated Cell Therapy
• ARMO BioSciences
• Eli Lilly
• ARMO BioSciences
• Dendreon

External person

Susan Geyer

• Ohio State University
• University of South Florida
• University of Texas MD Anderson Cancer Center
• Health Informatics Institute
• Department of Internal Medicine
• Division of Hematology
• Department of Biostatistics
• Division of Hematology
• Alliance Statistics and Data Center
• Comprehensive Cancer Center
• Mayo Clinic Rochester, MN

External person

Teresa Macarulla

• Vall d'Hebron University Hospital
• Autonomous University of Barcelona
• Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology
• Vall d'Hebron Institute of Oncology (VHIO)
• Vall d'Hebron Institute of Oncology
• Department of Medical Oncology
• Medical Oncology Department
• Medical Oncology Department
• Vall d'Hebron Institute of Oncology
• Vall d'Hebron General Hospital

External person

Giampaolo Perri

• University of Texas MD Anderson Cancer Center
• Ospedale Policlinico
• University of Verona

External person

Mansoor Saleh

• Genentech Incorporated
• University of Alabama at Birmingham
• Georgia Cancer Specialists
• University of Alabama
• Eli Lilly
• Wallace Tumor Institute 223
• Georgia Cancer Specialists
• Mayo Clinic Rochester, MN
• Northwestern University
• Biogen IDEC
• Washington University St. Louis
• Fox Chase Cancer Center
• University of Texas MD Anderson Cancer Center
• Department of HematologylOncology
• Division of Hematology/Oncology
• Fox Chase Cancer Research Center
• Comprehensive Cancer Center
• Robert H. Lurie Comprehensive Cancer Center of Northwestern University
• Fox Chase Cancer Centre
• Aga Khan University
• University of Texas Southwestern Medical Center

External person

Lacey McQuinn

• University of Texas Health Science Center at Houston
• University of Texas MD Anderson Cancer Center
• University of Evansville

External person

Bhuvaneswari Ramaswamy

• Ohio State University
• Division of Medical Oncology
• Division of Medical Oncology
• Comprehensive Breast Health Services
• Division of Hematology/Oncology
• Department of Internal Medicine
• Department of Internal Medicine
• Stefanie Spielman Comprehensive Breast Center
• The Breast Cancer Research Program
• Breast Program
• Department of Internal Medicine
• Division of Hematology/Oncology
• Division of Medical Oncology
• Division of Medical Oncology Department
• Richard J. Solove Research Institute

External person

Raid Aljumaily

• Sarah Cannon Research Institute
• University of Oklahoma
• Department of Internal Medicine
• Stephenson Cancer Center
• Sarah Cannon Research Institute
• Oncology
• Oklahoma University
• OUHSC

External person

Karim A. Benhadji

• Eli Lilly
• Taiho Oncology Inc.
• Inc.

External person

Kevin Moore

• University of California at San Diego
• Department of Radiation Medicine and Applied Sciences
• University of Oklahoma
• Stephenson Cancer Center
• Sarah Cannon Research Institute
• Stephenson Cancer Center/Sarah Cannon Research Institute
• Stephenson Oklahoma Cancer Center
• Section of Gynecologic Oncology
• Department of Gynecologic Oncology
• Sarah Cannon Research Institute
• Gynecologic Oncology
• Stephenson Cancer Center
• Stephenson Cancer Center
• Sarah Cannon Research Institute/Tennessee Oncology
• Gynecologic Oncology Group-Foundation (GOG-F)
• Oklahoma City

External person

Mark Zalupski

• University of Michigan, Ann Arbor
• Wayne State University
• Biostatistics Unit
• Division of Pulmonary and Critical Care Medicine
• Department of Internal Medicine
• Department of Hematology and Oncology
• Department of Radiation Oncology
• Department of Internal Medicine
• Divisions of Infectious Diseases and Hcmatology-Oncologv

External person

Ming Sun

• University of Texas MD Anderson Cancer Center
• Nanjing Medical University
• Department of Biochemistry and Molecular Biology
• Department of Oncology

External person

Joann Lim

• Department of Investigational Cancer Therapeutics
• University of Texas MD Anderson Cancer Center
• Pharamacy Clinical Programs
• University of Texas Health Science Center at Houston

External person

Renuka Iyer

• Departments of Medicine
• Roswell Park Cancer Institute
• State University at Buffalo
• State University of New York at Buffalo
• SUNY Buffalo
• Department of Medicine
• Department of Medicine
• Department of Medicine
• Department of Medicine
• Department of Medical Oncology
• Leukemia Service Department
• Department of Medical Oncology
• Roswell Park Cancer Center
• Roswell Park Comprehensive Cancer Center
• Department of Medicine
• Roswell Park Comprehensive Cancer Center

External person

John Sarantopoulos

• University of Texas Health Science Center at San Antonio
• University of Texas Health Science Center San Antonio
• University of Texas at San Antonio
• Institute for Drug Development
• Vanderbilt University
• Institute for Drug Development
• University of Texas Health Science Center

External person

Stacie Bean

• University of Texas MD Anderson Cancer Center
• Pharamacy Clinical Programs
• Department of Pharmacy

External person

Andrew H. Ko

• University of California at San Francisco
• University of California at San Francisco
• UCSF Helen Diller Family Comprehensive Cancer Center
• UCSF Helen Diller Family Comprehensive Cancer Center
• Department of Internal Medicine
• Department of Medicine
• Division of Hematology and Oncology
• Department of Surgery
• Erasmus University Rotterdam
• 1UCSF Helen Diller Family Comprehensive Cancer Center

External person

Shiraj Sen

• University of Texas MD Anderson Cancer Center
• Department of Investigational Cancer Therapeutics (Phase I Program)
• Sarah Cannon Research Institute
• HealthOne
• Sarah Cannon Research Institute

External person

Hendrik Tobias Arkenau

• Sarah Cannon Research Institute
• University of Oklahoma
• Sarah Cannon Research Institute UK
• GlaxoSmithKline
• University College London
• Prince of Wales Hospital
• Institute of Cancer Research
• Royal Marsden NHS Foundation Trust
• Sarah Cannon Research Institute
• Drug Development Unit
• Sarah Cannon Research Institute
• Drug Development Unit
• Cancer Institute
• Royal Marsden Hospital
• Oncology
• SCRI
• The Institute of Cancer Research, London
• UCL Cancer Institute
• HCA Laboratories
• Royal Marsden Hospital, Sutton
• Ellipses Pharma

External person

A. Craig Lockhart

• Washington University School of Medicine
• Barnes-Jewish Hospital and Washington University School of Medicine
• Washington University St. Louis
• Barnes-Jewish Hospital and Siteman Cancer Center
• Vanderbilt University
• University of Miami
• Diabetes Research Institute
• Sylvester Comprehensive Cancer Center
• Division of Oncology

External person

Nilli Sommovilla

• Mount Sinai School of Medicine
• Icahn School of Medicine at Mount Sinai
• Department of Internal Medicine

External person

Eunice Yuen

• Eli Lilly

External person

Navneet P. Ratti

• ARMO BioSciences
• Eli Lilly
• ARMO BioSciences
• Synthkine
• a wholly owned subsidiary of Eli Lilly and Company

External person

Roman Groisberg

• University of Texas MD Anderson Cancer Center
• Department of Investigational Cancer Therapeutics (Phase I Program)
• Department of Medical Oncology
• Rutgers Cancer Institute of New Jersey
• Department of Medical Oncology
• Rutgers - The State University of New Jersey, New Brunswick
• University of Texas Health Science Center at Houston
• Rutgers Cancer Institute of New Jersey
• Cancer Institute of New Jersey
• Rutgers University
• Merck

External person

Raid Aljumaily

• University of Oklahoma
• Sarah Cannon Research Institute

External person

Jatin J. Shah

• University of Texas MD Anderson Cancer Center
• Department of Hematopathology
• Inc.
• University of Texas Health Science Center at Houston
• Inc

External person

Charles L. Shapiro

• The Ohio State University
• Ohio State University
• Dana-Farber Cancer Institute
• Brown University
• Duke University
• The University of Chicago
• Boston Dana-Farber Cancer Institute
• James Cancer Center
• Columbus OH
• James Cancer Hospital
• Department of Internal Medicine
• Comprehensive Breast Health Services
• Division of Cancer Prevention and Control
• Wexner Medical Center
• Division of Medical Oncology
• Department of Hermatology and Oncology
• Arthur G. James Cancer Hospital
• Division of Hematology/Oncology
• James Cancer Hospital
• Arthur G. James Cancer Hospital
• Division of Medical Oncology
• Division of Hematology/Oncology
• Stefanie Spielman Comprehensive Breast Center
• The Breast Cancer Research Program
• Division of Medical Oncology
• Comprehensive Cancer Center
• Breast Program
• James Cancer Center
• Comprehensive Cancer Center
• Division of Hematology/Oncology
• Department of Internal Medicine
• Division of Medical Oncology
• Division of Medical Oncology Department
• University of Pennsylvania
• Icahn School of Medicine at Mount Sinai
• Mount Sinai Hospital Medical Center
• Dana-Farber Cancer Institute

External person

Katherine Van Loon

• University of California at San Francisco
• University of California at San Francisco
• Department of Internal Medicine
• Department of Medicine

External person

Mark W. Hurd

• University of Texas MD Anderson Cancer Center
• Sheikh Ahmed Pancreatic Cancer Research Center
• UT MD Anderson Cancer Center
• University of Texas Health Science Center at Houston

External person

Ludmila K. Martin

• Ohio State University
• Department of Internal Medicine
• Division of Medical Oncology

External person

Lai Wei

• Department of Internal Medicine
• Ohio State University
• Department of Biostatistics
• Wexner Medical Center
• Center for Biostatistics
• Division of Biostatistics
• Department of Biomedical Informatics
• Center for Biostatistics

External person

Erika Hamilton

• Sarah Cannon Research Institute
• Department of Medical Oncology
• Division of Gynecologic Oncology
• Sarah Cannon Research Institute
• Tennessee Oncology
• Sara Cannon Research Institute
• Sarah Cannon Research Institute/Tennessee Oncology

External person

S. Percy Ivy

• National Institutes of Health
• Cancer Therapy Evaluation Program
• Investigational Drug Branch
• Division of Cancer Treatment and Diagnosis

External person

Howard Ozer

• American Society of Clinical Oncology
• CSF Review Committee
• Forsyth Memorial Hospital
• Forsyth Medical Center
• University of Oklahoma
• University of North Carolina at Chapel Hill
• CSF Review Committee
• Department of Internal Medicine
• Cancer Research Program, Oklahoma Medical Research Foundation, and Department of Medicine
• Division of Medical Oncology
• University of Illinois at Chicago
• American Society of Clinical Oncology

External person

Ofir Moreno

• MEI Pharma, Inc.

External person

Antoine Italiano

• Université de Bordeaux
• Institut Bergonié
• Centre Georges-François Leclerc
• Department of Oncology
• Centre Régional de Lutte Contre le Cancer de Bordeaux et du Sud-Ouest
• Sarcoma Unit
• Bergonie Cancer Institute
• Institut Gustave Roussy
• Gustave Roussy
• ComUE Paris-Saclay

External person

John B. Mumm

• Univ. TX M. D. Anderson Cancer Ctr.
• Schering Plough Biopharma
• Box 422
• Schering-Plough Biopharma
• University of Texas MD Anderson Cancer Center
• ARMO BioSciences
• Merck
• Eli Lilly
• ARMO BioSciences
• Department of Bioimmunotherapy
• University of Texas Health Science Center at Houston

External person

Do Youn Oh

• Seoul National University
• Masaryk University
• Department of Internal Medicine
• Department of Internal Medicine
• Cancer Research Institute
• Department of Internal Medicine
• Department of Medical Oncology
• University of Texas MD Anderson Cancer Center
• Cancer Research Institute

External person

Michael S. Gordon

• John Wayne Cancer Institute
• Pinnacle Oncology Hematology
• University of Arizona
• Aragen Inc
• Premiere Oncology of Arizona
• Indiana University-Purdue University Indianapolis
• Kosan Biosciences, Inc.
• Mem. Sloan Kettering Cancer Center
• Indiana Univ. School Medicine
• Mem. Sloan-Kettering Cancer Center
• Indiana Univ. School of Medicine
• Memorial Sloan-Kettering Cancer Center
• Pinnacle Oncology Hematology
• GlaxoSmithKline
• Honor Health Research Institute
• Collegeville
• Department of Medicine
• College of Medicine
• Department of Medicine
• Walther Oncology Center
• Hematology/Oncology Section
• Hematology-Oncology Section
• Hematoiogy-Oncology Section
• Saint John's Health Center
• Department of Medicine
• HonorHealth Research Institute
• AZ
• Indiana University Bloomington
• HonorHealth, Arizona

External person

D. Adkins

• Washington University School of Medicine
• Siteman Cancer Center, Barnes-Jewish Hospital, Washington University
• Washington University in St Louis
• Washington University St. Louis
• Washington Univ. School of Medicine
• Case Western Reserve University
• University of Washington
• Siteman Cancer Center
• Division of Oncology
• Department of Internal Medicine
• Johns Hopkins University
• Robert H. Lurie Comprehensive Cancer Center of Northwestern University
• Northwestern University

External person

David S. Wages

• Inc.
• EMD Serono

External person

Patricia LoRusso

• Karmanos Cancer Institute/Wayne State University
• Wayne State University
• Karmanos Cancer Institute
• Barbara Ann Karmanos Cancer Center
• Wayne State University-Barbara Ann Karmanos Cancer Institute
• Baylor Health Care System
• Karmanos Cancer Center
• Pinnacle Oncology Hematology
• Yale University
• Yale Cancer Center
• Department of Medical Oncology
• Phase i Clinical Trials Program
• Eisenberg Center for Translational Therapeutics
• Yale School of Medicine
• Department of Medical Oncology
• Department of Breast Medical Oncology
• Yale New Haven Health System
• Smilow Cancer Hospital at Yale-New Haven

External person

Natalie Y.L. Ngoi

• National University of Singapore
• MOH Holdings Pte Ltd.
• University of Texas MD Anderson Cancer Center
• Chemoprevention Branch
• National University Cancer Institute
• National University Cancer Institute
• National University Cancer Institute

External person

Patrick Murphy

• PLLC/SCRI
• Sarah Cannon Research Institute
• Tennessee Oncology PLLC
• Sarah Cannon Research Institute

External person

Donastas Sakellariou-Thompson

• University of Texas MD Anderson Cancer Center

External person

Martin Gutierrez

• John Theurer Cancer Center
• Department of Hematology
• University of Medicine and Dentistry of New Jersey
• Department of Hematology/Oncology
• Department of Hematology and Oncology
• Hackensack University
• Rutgers - The State University of New Jersey, Newark
• Regional Cancer Care Associates

External person

L. Eberst

• Centre Léon Bérard
• Department of Medical Oncology
• Universite Claude Bernard Lyon 1

External person

Manish Patel

• Florida Cancer Specialists
• Sarah Cannon Research Institute

External person

Jessica M. Frakes

• Department of Surgery
• Erasmus University Rotterdam
• University of South Florida

External person

Martin Schuler

• La Jolla Inst. for Allerg./Immunol.
• University Duisburg-Essen
• University of Duisburg-Essen
• La Jolla Institute for Allergy and Immunology
• University of Duisburg-Essen
• German Cancer Research Center
• West German Cancer Center
• West German Cancer Center
• West German Cancer Center
• 3 Present Address: Div. of Immunochemistry
• Department of Medical Oncology

External person

Judy S. Wang

• Sarah Cannon Research Institute
• Florida Cancer Specialists
• Sarah Cannon Research Institute

External person

D. Scott McMeekin

• Oklahoma University Health Science Center
• Univ. of OK Health Sciences Center
• University of Oklahoma
• Sarah Cannon Research Institute
• Department of Obstetrics and Gynecology
• Department OfObstetrics AndGynecology
• Department of Gynecologic Oncology
• Stephenson Cancer Center
• Department of Gynecologic Oncology
• Division of Gynecologic Oncology
• Division of Gynecologic Oncology
• Sarah Cannon Research Institute

External person

W. Michael Korn

• UCSF Helen Diller Family Comprehensive Cancer Center
• University of California at San Francisco
• UCSF Helen Diller Family Comprehensive Cancer Center
• Department of Medicine
• Caris Life Sciences

External person

Yoon Koo Kang

• ASAN Medical Center
• Asan Medical Centre
• Asian Medical Center
• University of Ulsan College of Medicine
• Asan Medical Center, University of Ulsan College of Medicine
• University of Ulsan
• University of Ulsan
• Department of Internal Medicine
• Division Oncology Department
• Department of Oncology
• Department of Internal Medicine
• Department of Oncology
• Seoul National University

External person

Hossein Maymani

• University of Texas MD Anderson Cancer Center
• Departments of Hematology and Medical Oncology
• University of Texas Health Science Center at Houston

External person

C. Terret

• Centre Léon Bérard
• Department of Medical Oncology

External person

Sunil Sharma

• University of Utah
• Memorial Sloan-Kettering Cancer Ctr.
• Huntsman Cancer Institute at the University of Utah
• Novartis USA
• Nevada Cancer Institute
• The Nevada Cancer Institute
• Mem. Sloan Kettering Cancer Center
• Huntsman Cancer Institute
• Roswell Park Cancer Institute
• Memorial Sloan-Kettering Cancer Center
• Salix Pharmaceuticals
• Novartis Pharmaceuticals Corporation
• University of Arkansas for Medical Sciences
• Huntsman Cancer Institute
• Huntsman Cancer Institute
• Center for Investigational Therapeutics
• Department of Medicine
• Center for Investigational Therapeutics
• Division of Oncology
• Section of Phase I
• Division of Medical Oncology
• Department of Internal Medicine
• Translational Genomics Research Institute
• Houston Methodist
• Cancer Center
• Salix Pharmaceuticals, Inc.
• University of California at San Diego
• Huntsman Cancer Institute
• University of Uta
• Novartis

External person

Lowell L. Hart

• Florida Cancer Specialists
• Sarah Cannon Research Institute
• Duke University
• Division of Radiation Oncology
• Florida Cancer Specialists
• Florida Cancer Specialists-Sarah Cannon Research Institute
• Florida Cancer Specialists/SCRI
• Sarah Cannon Research Institute
• Medical Oncology
• Wake Forest University
• Florida Cancer Specialists

External person

Geena G. Mathew

• Department of Radiation Oncology
• Division of Radiation Oncology
• University of Texas MD Anderson Cancer Center
• University of Texas Health Science Center at Houston

External person

Takeaki Suzuki

• FUJIFILM Pharmaceuticals U.S.A., Inc.
• Inc.

External person

Manish R. Patel

• Florida Cancer Specialists
• Sarah Cannon Research Institute
• Ohio State University
• Sarah Cannon Research Institute
• Sarah Cannon Research Institute
• Drug Development Unit
• Sarah Cannon Research Institute

External person

Gerard Joseph Oakley

• Eli Lilly

External person

Todd A. Aguilera

• Stanford University
• Division of Radiation and Cancer Biology
• University of Texas Southwestern Medical Center

External person

Saikat Chowdhury

• University of Texas MD Anderson Cancer Center

External person

Jin Won Kim

• Seoul National University
• Department of Internal Medicine

External person

Shuang Liu

• University of Texas MD Anderson Cancer Center
• Utmdacc

External person

Vincent Chung

• City of Hope National Medical Center
• City of Hope Comprehensive Cancer Center
• City of Hope National Med Center
• Dept of Medical Oncology and Therapeutics Research
• City of Hope NationalMedical Center

External person

Lilibeth Castillo

• University of Texas MD Anderson Cancer Center
• University of Texas Health Science Center at Houston

External person

Roberto Carlesi

• Eli Lilly Italia
• Eli Lilly Italia
• Eli Lilly
• Eli Lilly Italia

External person

Timothy Madden

• TAP Pharmaceutical Products Inc.
• University of Texas M.D Anderson Cancer Center
• M.D. Anderson Cancer Center
• University of Texas M.D. Anderson Cancer Center
• Univ. Texas M. D. Anderson Cancer C.
• The University of Texas M.D. Anderson Cancer Center
• Univ. Tex. M.D. Anderson Cancer Ctr.
• Box 90
• University of Cambridge
• M.D. Anderson Cancer Center Houston
• M. D. Anderson Cancer Center
• University of Texas at Austin
• University of Texas MD Anderson Cancer Center
• National Institutes of Health
• InPharma LLC
• Dept. of Pharmaceutical Sciences
• Department of Experimental Therapeutics
• Department of Breast Medical Oncology
• Clin. Pharmacology Resource Facility
• Department of Experimental Therapeutics
• Pharmaceutical Development Center
• Department of Pharmacy
• Department of Pharmacy
• Department of Experimental Therapeutics
• Department of Experimental Therapeutics
• Department of Experimental Therapeutics and Pharmaceutical Development Center
• Department of Cellular Pharmacology
• Dept. of Pharmaceutical Research
• Dept. of Experimental Pediatrics
• Department of Clinical Pharmacology
• Dept. of Molec. Hematol. and Therapy
• InPharma, LLC.
• University of Texas Health Science Center at Houston
• FUJIFILM Pharmaceuticals U.S.A., Inc.
• Inc.

External person

Analia Azaro

• Autonomous University of Barcelona
• Early Clinical Drug Development Group
• Molecular Therapeutics Research Unit
• Medical Oncology Department
• Pharmacology Department
• Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology
• Vall d'Hebron Institute of Oncology (VHIO)
• Medical Oncology Department
• Vall d'Hebron Institute of Oncology
• Vall d'Hebron Institute of Oncology
• Vall d'Hebron General Hospital

External person

Enedelia Rodriguez

• University of Texas MD Anderson Cancer Center

External person

Catherine Wheeler

• Acetylon Pharmaceuticals Inc.
• Inc.

External person

Alexandra Drakaki

• University of California at Los Angeles

External person

Ruth Ann Subach

• Trevena Inc.
• Trevena, Inc.
• FUJIFILM Pharmaceuticals U.S.A., Inc.
• Inc.

External person

Danni Yu

• Eli Lilly

External person

Manisha Palta

• Duke University
• Duke Cancer Institute
• Department of Radiation Oncology
• Department of Radiation Oncology
• Department of Radiation Oncology

External person

G. Abbadessa

• ArQule, Inc.
• ArQule, Inc.
• Sanofi Genzyme
• Sanofi Genzyme
• Genzyme Corporation
• University of Texas MD Anderson Cancer Center

External person

Justin T. Moyers

• University of Texas MD Anderson Cancer Center
• University of California at Irvine
• Angeles Clinic and Research Institute
• Cedars-Sinai Medical Center

External person

E. Copelan

• Cleveland Clinic Foundation
• The Ohio State University
• Blood Disorders
• Carolinas HealthCare System
• Carolinas Healthcare System
• Ohio State University
• Taussig Cancer Institute
• Memorial Sloan-Kettering Cancer Center
• Carolinas Health Care System
• Carolinas Health Care System
• Carolinas Health Care System
• Department of Hematologic Oncology and Blood Disorders
• Levine Cancer Institute
• Department of Hematologic Oncology and Blood Disorders
• Levine Cancer Institute
• Arthur G. James Cancer Hospital
• Department of Bone Marrow Transplant
• Hematology/Oncology and Blood and Marrow Transplant
• Department of Hematologic Oncology
• Department of Hematologic Oncology
• Department of Hematologic Oncology and Blood Disorders
• Department of Hematology and Oncology
• Arthur G. James Cancer Hospital
• Atrium Health
• Levine Cancer Institute
• Carolinas HealthCare System
• Levine Cancer Institute

External person

Shalini Moningi

• University of California at San Francisco
• Johns Hopkins University
• University of Texas MD Anderson Cancer Center
• Department of Radiation Oncology and Molecular Radiation Sciences
• Department of Radiation Oncology and Molecular Radiation Sciences
• Department of Radiation Oncology and Molecular Radiation Sciences
• Department of Radiation Oncology and Molecular Radiation Sciences
• Division of Radiation Oncology
• University of Texas Health Science Center at Houston
• Harvard University
• Brigham and Women’s Hospital

External person

Xiaofei Zhou

• Takeda Pharmaceutical Company Limited
• a wholly owned subsidiary of Takeda Pharmaceutical Company Limited
• Takeda Pharmaceuticals International Co.
• Quantitative Clinical Pharmacology
• Millennium Pharmaceuticals

External person

Sarah Hoffe

• Moffitt Cancer Center
• University of South Florida
• Moffitt Cancer Center
• Department of Radiation Oncology
• Department Radiation Oncology
• City of Hope National Med Center

External person

Shukui Qin

• People's Liberation Army (PLA) 81 Hospital
• Nanjing Bayi Hospital
• No. 81 Hospital of PLA
• The 81st Hospital of Chinese PLA
• Nanjing University
• 180tieth Hospital of People's Liberation Army
• Cancer Center of People's Liberation Army
• PLA Cancer Centre
• No. 81th PLA Hospital Nanjing
• People's Liberation Army 81 Hospital
• The 81st Hospital of P.L.A.
• Department of Medical Oncology
• 81st Hospital of PLA
• PLA Hospital of Bayi
• Nanjing University of Chinese Medicine
• The 81 Hospital of the Chinese People's Liberation Army
• 81st Hospital of People's Liberation Army
• 81st Hospital of PLA
• Nanjing Chinese Medicine University
• 81 Hospital of PLA
• 81 Military Hospital of China
• The 307 Hospital of Chinese People’s Liberation Army
• The 81 Hospital of People's Liberation Army of China
• Sichuan University
• Nanjing Eight One Hospital
• Peking University

External person

Ademi Santiago-Walker

• GlaxoSmithKline
• Janssen Research
• Johnson and Johnson Pharmaceutical Research and Development
• Johnson & Johnson

External person

Scott McCauley

• ARMO BioSciences
• Eli Lilly
• ARMO BioSciences
• Synthkine

External person

S. McNeely

• Eli Lilly

External person

John Nemunaitis

• Mary Crowley Medical Research Center
• Mary Crowley Cancer Research Centers
• U.S. Oncology
• Introgen Therapeutics, Inc.
• Fred Hutchinson Cancer Research Center
• Baylor University
• Baylor Health Care System
• Texas Oncology
• US Oncology, Inc.
• Indiana Univ. School Medicine
• Indiana University-Purdue University Indianapolis
• Mary Crowley Cancer Center
• Mary Crowley Cancer Research Centers
• University of Texas MD Anderson Cancer Center
• Clinical Research
• Mary Crowley Cancer Research Centers Dallas
• Fred Hutchison Cancer Research Center
• Biotechwrite: Biomedical and Science Communications
• Okayama University
• Department of Thoracic and Cardiovascular Surgery
• Division of Surgical Oncology
• PRN Research Inc.
• Walther Oncology Center
• University of Toledo
• Department of Medicine
• Indiana University Bloomington
• Department of Medical Affairs
• University of Texas Health Science Center at Houston
• Gradalis, Inc.
• US Oncology, Inc.

External person

Ivan H. Chan

• ARMO BioSciences
• Eli Lilly
• ARMO BioSciences

External person

J. Fan

• Institute of Biomedical Sciences of Fudan University
• Shanghai Medical University
• Fudan University
• Fudan University
• Department of Liver Surgery
• Institute of Biomedical Sciences
• Liver Cancer Institute
• Liver Cancer Institute
• Molecular and Cell Biology Lab.
• Key Laboratory of Carcinogenesis and Cancer Invasion
• Ministry of Education, China
• University of Michigan, Ann Arbor

External person

Irina Mihaela Cazacu

• Department of Gastroenterology
• University of Texas MD Anderson Cancer Center
• Department of Gastroenterology
• Universitatea de Medicina si Farmacie din Craiova
• Department of Gastroenterology, Hepatology, and Nutrition
• Hepatology and Nutrition
• Research Center of Gastroenterology and Hepatology
• Craiova University of Medicine and Pharmacy
• University of Texas at Austin
• Department of Gastroenterology
• University of Medicine and Pharmacy
• University of Medicine and Pharmacy
• University of Texas Health Science Center at Houston
• Research Center of Gastroenterology and Hepatology
• Fundeni Clinical Institute
• Titu Maiorescu University
• Carol Davila University of Medicine and Pharmacy

External person

Amber M. Johnson

• UT MD Anderson Cancer Center
• University of Texas MD Anderson Cancer Center
• Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy
• Institute of Personalized Cancer Therapy
• Sheikh Khalifa Bin Zayed Al Nahyan
• University of Texas Health Science Center at Houston

External person

J. Holmlund

• Galera Therapeutics, Inc
• Ascenta Therapeutics

External person

S. V. Ulahannan

• National Institutes of Health
• Center for Cancer Research
• Gastrointestinal Malignancies Section
• University of Oklahoma
• Sarah Cannon Research Institute
• OKLAHOMA CITY

External person

Dina Demner-Fushman

• National Institutes of Health

External person

M. Johansen

• M.D. Anderson Cancer Center
• The University of Texas M.D. Anderson Cancer Center
• University of Texas M.D. Anderson Cancer Center
• University of Texas MD Anderson Cancer Center
• Strategia Therapeutics, Inc.
• Univ. TX M. D. Anderson Cancer Ctr.
• Department of Pharmacy
• Departments of Experimental Therapeutics
• Depts. Anesthesia Critical Care T.
• Department of Experimental Therapeutics
• Strategia Therapeutics, Inc
• University of Texas Health Science Center at Houston
• Takeda Pharmaceuticals U.S.A. Inc.
• FUJIFILM Pharmaceuticals U.S.A., Inc.
• Inc.

External person

Kirk Roberts

• University of Texas Health Science Center at Houston

External person

Deby C. Ogbonna

• University of Texas MD Anderson Cancer Center

External person

Sarah Hopps

• University of Oklahoma
• Oklahoma University
• Department of Pharmacy
• Health Sciences Center

External person

Dana Thompson

• PLLC/SCRI
• Sarah Cannon Research Institute
• Sarah Cannon Research Institute

External person

Russell G. Postier

• University of Oklahoma
• Department of Surgery
• Department of Surgery

External person

Kyaw Zin Thein

• University of Texas MD Anderson Cancer Center
• Texas Tech University Health Sciences Center
• Division of Hematology/Oncology
• Division of Hematology
• Division of Internal Medicine
• Oregon Health and Science University

External person

Gurudatta Naik

• Kyoto University
• University of Alabama at Birmingham
• Department of Epidemiology
• Department of Epidemiology
• Department of Epidemiology
• Department of Epidemiology
• Department of Epidemiology
• Department of Epidemiology
• Department of Epidemiology
• Department of Epidemiology
• Comprehensive Cancer Center
• Department of Epidemiology
• Barcelona Institute for Global Health

External person

Mohamad Khawandanah

• University of Oklahoma
• Department of Medicine
• Section of Hematology-Oncology

External person

Daneng Li

• Dept of Medical Oncology and Therapeutics Research
• City of Hope National Med Center
• Memorial Sloan-Kettering Cancer Center

External person

Daniel Laheru

• Johns Hopkins University
• Johns Hopkins University School of Medicine
• Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
• Research Bldg
• Northwestern University
• Sol Goldman Pancreatic Cancer Research Center
• University of California at San Francisco
• Thomas Jefferson University
• Sol Goldman Pancreatic Cancer Research Center
• The Skip Viragh Center for Pancreatic Cancer
• Department of Medical Oncology
• Sidney Kimmel Comprehensive Cancer Center
• The Sol Goldman Pancreatic Cancer Research Center
• Department of Oncology
• Department of Medical Oncology
• Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
• Department of Medical Oncology
• Departments of Surgery
• Department of Oncology
• Department of Medical Oncology
• Department of Radiation Oncology and Molecular Radiation Sciences
• Skip Viragh Center for Pancreas Cancer Clinical Research and Patient Care
• Division of Medical Oncology
• Departments of Oncology and Pathology
• Sidney Kimmel Comprehensive Cancer Center
• Departments of Medicine
• Department of Surgery
• McKusick-Nathans Institute of Genetic Medicine
• Department of Oncology
• The Pancreatic Cancer Precision Medicine Center of Excellence Program
• Robert H. Lurie Comprehensive Cancer Center of Northwestern University

External person

Tomislav Dragovich

• University of Arizona
• University of Texas MD Anderson Cancer Center
• Hematology-Oncology
• Banner MD Anderson Cancer Specialists
• AZ
• AZ
• Banner Health

External person

Madappa Kundranda

• Banner Health

External person

Brian G. Czito

• Box 3118
• Duke University
• Duke University Medical Center
• Duke Cancer Institute
• Duke Cancer Institute
• Department of Radiation Oncology
• Department of Radiation Oncology
• Department of Radiation Oncology
• Department of Radiation Oncology
• Department of Radiation Oncology
• Department of Radiation Oncology
• Duke Cancer Institute
• 9Duke Cancer Institute

External person

Bailey Anderson

• Eli Lilly

External person

Xiaohong Yan

• Mirati Therapeutics

External person

Sanjay Goel

• Yeshiva University
• Department of Oncology
• Department of Medical Oncology
• Mayo Clinic Scottsdale, AZ
• Montefiore Health System
• Albert Einstein College of Medicine
• Albert Einstein College of Medicine

External person

Ellen M. Voorhees

• National Institute of Standards and Technology

External person

Veronica R. Holley

• The MD Anderson Cancer Center
• University of Texas MD Anderson Cancer Center
• Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
• Department of Investigational Cancer Therapeutics (Phase I Program)
• University of Texas Health Science Center at Houston

External person

Victoria M. Raymond

• University of Michigan School of Public Health
• University of Michigan, Ann Arbor
• Division of Pulmonary and Critical Care Medicine
• Guardant Health, Inc.
• Guardant Health
• Medical Affairs
• Inc.
• Inc

External person

Chirayu Mohindroo

• University of Texas MD Anderson Cancer Center
• Sinai Hospital of Baltimore

External person

Rakesh Verma

• ARMO BioSciences
• a wholly owned subsidiary of Eli Lilly and Company
• Eli Lilly

External person

K. Venkatakrishnan

• MD Anderson Cancer Center Orlando
• Takeda Pharmaceutical Company Limited
• a wholly owned subsidiary of Takeda Pharmaceutical Company Limited
• Orlando Regional Medical Center
• Quantitative Clinical Pharmacology
• Millennium Pharmaceuticals
• Millennium Pharmaceuticals

External person

Joud Hajjar

• Virginia Commonwealth University
• Baylor College of Medicine
• Texas Children's Hospital
• Section of Immunology
• Department of Immunology
• Departments of Internal Medicine
• Department of Immunology Allergy and Rheumatology
• Texas Children's Hospital Houston

External person

R. Kurzrock

• University of Texas M.D. Anderson Cancer Center
• Department of Hematology
• Texas Children's Hospital
• Box 0422
• Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
• Box 302
• Unit 455
• Universityof Texas M. D. Anderson Cancer Center
• M.D. Anderson Cancer Center
• University of Texas at Austin
• University of Texas, M.D. Anderson Cancer Center
• Moores Cancer Center-University of California San Diego
• UT M.D. Anderson Cancer Cent.
• Division of Hematology-Oncology, UC San Diego Moores Cancer Center
• The University of Texas MD Anderson Cancer Center
• Phase I Program
• Univ. TX M.D. Anderson Cancer Ctr.
• Univ. Texas M. D. Anderson Cancer C.
• U.T. M.D. Anderson Cancer Center
• Univ. Texas M.D. Anderson Cancer C.
• University of California San Diego
• Box # 302
• Unit 422
• Box 422
• Division of Hematology and Oncology, Center for Personalized Cancer Therapy, University of California San Diego Moores Cancer Center
• Department of Investigational Cancer Therapeutics (Phase I Program)
• Univesity of Texas
• M. D. Anderson Cancer Center
• University of Texas Health Science Center at Houston
• Clinical Immunology and Biological Therapy M.D. Anderson Cancer Center Houston
• Department of Investigational Cancer Therapeutics, University of Texas, M. D. Anderson Cancer Center
• Tumor Institute
• Univ of Texas, MD Anderson Canc Ctr
• Bristol-Myers Squibb
• Dana-Farber Cancer Institute
• UC San Diego Moores Cancer Center
• University of Texas MD Anderson Cancer Center
• UT-M. D. Anderson Cancer Center
• University of California at San Diego
• Repligen Corporation
• Johnson and Johnson Pharmaceutical Research and Development
• the University of Texas M.D. Anderson Hospital
• U. T. M. D. Anderson Cancer Center
• The University of Texas, M.D. Anderson Cancer Center
• The University of Texas M.D. Anderson Cancer Center
• Exelixis
• Box 61
• Drexel University
• University of Texas Graduate School of Biomedical Sciences Houston
• Cancer Center, Box 41
• Unit 0455
• Moores Cancer Center - University of California San Diego
• FC8.2057
• A Phase I Program
• M.D. Anderson Hospital
• Anderson Hospital
• Dept. Hematol., Clin. Immunol., B.
• Worldwide Innovative Network in Personalized Cancer Medicine
• University of Texas MD Anderson Cancer Center
• UC San Diego Moores Cancer Center
• University of Tübingen
• Universidade Estadual de Campinas
• American Society of Clinical Oncology
• Department of Clinical Immunology and Biological Therapy
• Clinical Immunology
• University of Vienna
• The University of Chicago
• Johns Hopkins University
• Fox Chase Cancer Center
• Memorial Sloan-Kettering Cancer Center
• Shanghai Jiao Tong University
• Rambam Health Care Campus Israel
• Tel Hashomer Hospital
• Center for Personalized Therapy Clinical Trials Office
• Houston Clinical Trials
• University of California Office of the President
• Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
• UCSD Moores Cancer Center
• University of California at San Diego Moores Cancer Center
• Division of Hematology and Oncology
• University of San Diego
• UCSD Moores Cancer Center
• Center for Personalized Cancer Therapy
• UC San Diego Medical Center
• Johnson & Johnson
• Department of Hematology
• Department of Bioimmunotherapy
• Department of Medicine
• Division of Hematology and Oncology
• Moores Cancer Center
• Department of Molecular Oncology
• Departments of Clinical Immunology and Biological Therapy
• Center for Personalized Therapy and Clinical Trials Office
• Phase I Program
• Center for Personalized Cancer Therapy
• Experimental Therapeutics Program
• Moores Cancer Center
• Department of Investigational Cancer Therapeutics
• Department of Leukemia
• Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program)
• Center for Personalized Cancer Therapy and Division of Hematology and Oncology
• Department of Internal Medicine
• Department of Medicine
• Department of Breast Medical Oncology
• The Departments of Clinical Investigation
• Department of Leukemia
• Phase I Program, Department of Investigational Cancer Therapeutics
• Department of Medicine
• Department of Cell Biology
• Center for Personalized Therapy and Clinical Trials
• Department of Gastrointestinal Medical Oncology
• Department of Hematology and Bone Marrow Transplantation
• Division of Hematology and Oncology
• Department of Experimental Therapeutics
• Cell Growth Regulation Laboratory
• Department of Medical Oncology
• Division of Hematology-Oncology
• Moores Cancer Center
• Departments of Medical Ontology
• UC San Diego
• Division of Hematology and Oncology
• Center for Personalized Cancer Therapy and Division of Hematology and Oncology
• Clinical Center for Targeted Therapy
• Phase 1 Program
• Department of Bioimmunotheraphy
• Department of Clinical Investigations
• Department of Bioimmunotherapy
• Dpt. Clin. Immun./Biol. Therap
• Section of Bone Marrow Transplantation
• Department of Cancer Medicine
• Depts. of Leukemia, Biostatistics and Applied Mathematics, Lymphoma/Myeloma, and Hematopathology
• Departments of Leukemia and Bioimmunotherapy
• Department of Biologic Studies
• Departments of Neurosurgery and Hematopathology
• Dept. of Clinical Investigations
• Departments of Internal Medicine I and Nuclear Medicine
• Dept. Clin. Immun./Biol. Ther.
• Department of Clinical Investigation
• Department of Oncology
• M.D. Anderson Cancer Center
• Department of Investigational Cancer Therapeutics
• Department of Experimental Therapeutics
• Departments of Experimental Therapeutics
• Department of Hematology and Oncology
• Center for Personalized Cancer Therapy and Division of Hematology and Oncology
• Department of Investigational Cancer Therapeutics-a Phase I
• UC San Diego Moores
• Center for Personalized Therapy
• Division of Hematology/Oncology
• Moores Cancer Center
• Worldwide Innovative Network (WIN) Association–WIN Consortium
• Department of Hematology/Oncology
• University of California at Berkeley
• Division of Hematology and Oncology
• Repligen Corporation
• Exelixis Inc.
• Biological Therapy
• Department of Clinical Immunology and Biological Therapy
• WIN Consortium
• University of Texas System
• American Society of Clinical Oncology
• WIN Consortium
• WIN Consortium
• Medical College of Wisconsin
• University of Nebraska Omaha
• Section of Leukocyte Biology
• WIN Consortium for Precision Medicine

External person

Patrick A. Ott

• New York University
• Dana-Farber Cancer Institute
• Dana-Farber/Brigham and Women's Cancer Center
• Melanoma Center
• Perlmutter Cancer Institute
• Department of Medical Oncology
• Center for Immuno-Oncology
• Department of Hematology/Oncology
• Vanderbilt University
• Dana-Farber/Brigham and Women's Cancer Center
• Dana-Farber/Brigham and Women’s Cancer Center
• Harvard University
• Broad Institute
• 25Dana-Farber/Brigham and Women's Cancer Center
• Dana-Farber/Brigham and Women's Cancer Center
• Brigham and Women’s Hospital

External person

Rachel Neuwirth

• Takeda Pharmaceuticals International Co.
• Takeda Pharmaceutical Company Limited
• Translational Medicine

External person

Sebastian Mondaca

External person

Aimee Bence Lin

• Eli Lilly

External person

Yixing Jiang

External person

Sara Lonardi

• IRCCS Istituto Oncologico Veneto
• IRCCS Istituto Oncologico Veneto - Padova

External person

Thian Kheoh

• Janssen Research and Development
• Janssen
• Ortho Biotech Oncology Research and Development (a Unit of Cougar Biotechnology)
• Cougar Biotechnology
• Janssen Research and Development
• Johnson & Johnson
• Janssen Research & Development
• Johnson and Johnson Pharmaceutical Research and Development
• Epidemiology and Biostatistics
• Janssen Research and Development
• Mirati Therapeutics
• Elicio Therapeutics

External person

Fawzi Benzaghou

• Ipsen

External person

Di Nguyen

• University of Texas Health Science Center at Houston

External person

Philip A. Philip

• Wayne State University
• Karmanos Medical Center
• Texas Univ. M.D. Anderson Can. Ctr.
• Karmanos Cancer Institute
• Karmanos Cancer Center
• University of Texas MD Anderson Cancer Center
• Department of Medical Oncology
• Division of Hematology and Oncology
• Division of Hematology and Oncology
• Department of Hematology and Oncology
• Department of Medical Oncology
• Department of Medicine
• University of Texas Health Science Center at Houston
• MI
• MI

External person

John R. Kalmar

• Ohio State University
• Academic Affairs and Graduate Studies

External person

Kawther Abdilleh

• Pancreatic Cancer Action Network

External person

J. Lavalle

• Memorial Sloan-Kettering Cancer Center

External person

S. Greg Call

• University of Texas MD Anderson Cancer Center

External person

F. Zohren

• Takeda Pharmaceutical Company Limited

External person

Meena P. Chilukuri

• Mount Carmel Medical Center
• Mount Carmel Health System

External person

Muddassir Syed

• University of Bologna
• University of Texas MD Anderson Cancer Center

External person

Bharvin K.R. Patel

• Eli Lilly

External person

Michael J. Schlosser

• COARE Biotechnology Inc.

External person

Daniel Ahn

• Ohio State University
• Mayo Clinic Scottsdale, AZ
• Department of Internal Medicine
• Division of Medical Oncology
• Department of Medicine
• Department of Medical Oncology
• Division of Gastroenterology and Hepatology
• Mayo Clinic Rochester, MN

External person

Diana Hanna

• University of Southern California
• Hoag Memorial Hospital

External person

Edward J. Kim

• University of Michigan, Ann Arbor
• Division of Pulmonary and Critical Care Medicine
• University of California at Davis
• Department of Internal Medicine
• Divisions of Infectious Diseases and Hcmatology-Oncologv

External person

Hecht J. Randolph

• University of California at Los Angeles

External person

Michael Blumenfeld

• Ohio State University
• Department of Obstetrics and Gynecology

External person

Erin B. Kennedy

• American Society of Clinical Oncology
• Emory University
• University of California at San Diego
• American Society of Clinical Oncology
• American Society of Clinical Oncology

External person

Thomas A. Mace

• Ohio State University
• Department of Internal Medicine
• Division of Gastroenterology
• Department of Internal Medicine

External person

Amita Patnaik

• START Center for Cancer Care
• South Texas Accelerated Research Therapeutics
• START
• Center for Cancer Care
• University of Texas Health Science Center at San Antonio
• South Texas Accelerated Research Therapeutics (START)
• University of South Florida
• South Texas Accelerated Research Therapeutics
• Department of Clinical Research
• Astellas Pharma Inc.
• Clinical Research
• Phase I Medical Oncology Program
• South Texas Accelerated Research Therapeutics
• Vanderbilt University
• Institute for Drug Development
• Clinical Research
• Medical Oncology
• South Texas Accelerated Research Therapeutics
• South Texas Accelerated Research Therapeutics
• Medical Oncology
• START San Antonio

External person

Theresa L. Werner

• University of Utah
• Huntsman Cancer Institute
• Department of Medicine

External person

Pamela Munster

• University of California at San Francisco
• University of South Florida
• Box 206
• Box 271
• Memorial Sloan-Kettering Cancer Center
• University of California Office of the President
• Division of Hematology and Oncology
• Department of Hematopathology and Laboratory Medicine
• Breast Medicine Service
• DrugDiscovery Program
• Department of Interdisciplinary Oncology and Biochemistry
• Division of Hematology and Oncology
• Eli Lilly
• Department of Malignant Hematology and Experimental Therapeutics Program
• Department of Hematology/Oncology
• Vanderbilt University
• Department of Medicine

External person

Christina S. Wu

• Ohio State University
• James Cancer Hospital
• Department of Internal Medicine
• Division of Medical Oncology
• Department of Hematology and Oncology
• Emory University
• Department of Hematology and Oncology
• Georgetown University

External person

S. T C Neuteboom

• Nereus Pharmaceuticals, Inc.
• Mirati Therapeutics

External person

Limin Zhu

• University of Texas MD Anderson Cancer Center

External person

Tingbo Liang

External person

James F. Griffin

• Piedmont Physicians Athens Surgical Oncology

External person

Esther Welkowsky

• Elicio Therapeutics

External person

Edward M. Chan

• Eli Lilly

External person

Stacey Stein

• Yale Cancer Center
• Yale University
• Rutgers - The State University of New Jersey, New Brunswick
• Cancer Institute of New Jersey

External person

Nataliya A. Uboha

• University of Wisconsin Carbone Cancer Center
• University of Wisconsin-Madison

External person

Tong Shen

• Ohio State University
• College of Pharmacy

External person

Michela Maur

• University of Modena and Reggio Emilia

External person

David C. Smith

• Division of Hematology/Oncology
• University of Michigan, Ann Arbor
• Comprehensive Cancer Center
• Comprehensive Cancer Center
• Department of Internal Medicine
• Departments of Medicine
• Duke University
• Division of Pulmonary and Critical Care Medicine
• Department of Internal Medicine
• Department of Radiation Oncology
• Cardiff and Vale NHS Trust

External person

Jennifer L. Gauvin

• GlaxoSmithKline
• Novartis Pharmaceuticals
• Novartis Pharmaceuticals Corporation
• Novartis

External person

Joseph Abi Jaoude

• University of Texas MD Anderson Cancer Center
• University of Texas Health Science Center at Houston
• Stanford University

External person

Arie Van Wieren

• Mayo Clinic Jacksonville, FL
• University of Texas MD Anderson Cancer Center

External person

Y. Wang

• ArQule, Inc.
• ArQule, Inc.

External person

Keunwook Lee

• Vanderbilt University
• Hallym University
• Yonsei University
• Department of Pathology
• Department of Urology
• Department of Urology
• Department of Clinical Oncology
• Aichi Cancer Center Hospital and Research Institute
• Department of Internal Medicine
• Seoul National University
• University of Texas MD Anderson Cancer Center
• University of Texas Health Science Center at Houston

External person

William McCulloch

• Alba BioPharm Advisors Inc.
• Sagimet Biosciences Inc.
• Sagimet Biosciences (formerly 3-V Biosciences)

External person

Peter J. Hosein

• University of Kentucky
• University of Miami
• Department of Medicine
• Department of Internal Medicine
• Department of Internal Medicine
• Department of Medicine
• Department of Internal Medicine
• Department of Surgery
• Erasmus University Rotterdam
• Sylvester Comprehensive Cancer Center

External person

Yong Wei

• Princeton University
• Ohio State University
• Department of Molecular Biology
• Department of Molecular Biology
• Department of Molecular Biology
• College of Pharmacy
• Department of Molecular Biology
• Department of Molecular Biology

External person

Kaushik Varadarajan

• University of Texas MD Anderson Cancer Center

External person

Kazunori Saeki

• Fujifilm Corporation

External person

John Marshall

• Wellcome Research Laboratories, London
• Georgetown University
• University of Texas at Austin
• Wellcome Sanger Institute
• University of Texas MD Anderson Cancer Center
• Cancer Genome Project
• Division of Hematology/Oncology
• Department of Medicine and Oncology
• Division of Hematology and Oncology
• Inova Comprehensive Cancer and Research Center
• Caris Life Sciences
• MedStar Georgetown University Hospital
• Massachusetts General Hospital

External person

Patrick Medina

• University of Oklahoma
• Health Sciences Center

External person

Andreas Geier

• Aachen University
• RWTH Aachen University
• University of Würzburg
• Department of Internal Medicine II

External person

Ravi Mehrotra

• Maulana Azad Medical College
• Institute of Cytology and Preventive Oncology (ICMR)
• Division of Molecular Oncology
• Division of Cytopathology
• Division of Molecular Oncology
• National Institute of Cancer Prevention and Research
• Barcelona Institute for Global Health
• National Institute of Cancer Prevention and Research
• Preventive Oncology
• Division of Preventive Oncology
• Janakpuri Super Specialty Hospital Society
• Neurology Department
• Indian Council of Medical Research
• Innovation and Policy Foundation
• Innovation and Policy Foundation
• Indian Cancer Genome Atlas
• Indian Cancer Genomic Atlas
• King's College London

External person

Lynn Matrisian

• Vanderbilt University
• Vanderbilt University School of Medicine
• Pancreatic Cancer Action Network
• National Institutes of Health
• Translational Research Working Group
• Department of Cancer Biology
• Coordinating Center for Clinical Trials
• Department of Cancer Biology

External person

Aaron Enke

• Takeda Pharmaceutical Company Limited
• Clovis Oncology

External person

Oluwadara Coker

• University of Texas MD Anderson Cancer Center

External person

M. Nusrat

• University of Texas UT Health Internal Medicine Residency Program
• University of Texas at Austin
• University of Texas Health Science Center at Houston
• Department of Internal Medicine
• University of Texas MD Anderson Cancer Center
• Department of Gastrointestinal Medical Oncology
• Memorial Sloan-Kettering Cancer Center

External person

Kari L. Kendra

• Richard J. Solve Research Institute
• Ohio State University
• Sarah Cannon Research Institute
• Division of Hematology/Oncology
• Arthur G. James Cancer Hospital
• Wexner Medical Center
• Department of Internal Medicine
• Sarah Cannon Research Institute

External person

Ashley Morgan

• University of Oklahoma

External person

B. J. Bolwell

• Cleveland Clinic Foundation
• Taussig Cancer Institute
• Department of Hematology and Oncology
• Department of Hematology and Medical Oncology
• Department of Bone Marrow Transplant
• Department of Hematologic Oncology
• Taussig Cancer Institute
• Bone Marrow Transplantation Program

External person

Graziela Zibetti Dal Molin

• A Beneficência Portuguesa de São Paulo
• University of Texas MD Anderson Cancer Center
• Ludwig Maximilian University of Munich
• Centro Oncológico BP Beneficência Portuguesa de São Paulo

External person

Martin Greco

External person

Jeane M. Painter

• University of Texas MD Anderson Cancer Center

External person

Ahmed Shalaby

• University of Texas MD Anderson Cancer Center
• University of Texas at Austin
• Department of Gastrointestinal Medical Oncology
• University of Texas Health Science Center at Houston
• University of Mississippi
• University of Medicine and Dentistry of New Jersey
• Robert Wood Johnson University Hospital

External person

Lihou Yu

• University of Texas MD Anderson Cancer Center
• University of Texas Health Science Center at Houston

External person

Neal Rebueno

• The University of Texas M. D. Anderson Cancer Center
• M. D. Anderson Cancer Center
• The University of Texas M.D. Anderson Cancer Center
• University of Texas MD Anderson Cancer Center
• M. D. Anderson Cancer Center
• M.D. Anderson Cancer Center
• Department of Radiation Dosimetry
• Department of Diagnostic Radiology
• University of Texas Health Science Center at Houston

External person

Keith Eaton

• University of Washington
• Seattle Cancer Care Alliance
• Fred Hutchinson Cancer Research Center
• Fred Hutchinson Cancer Research Center

External person

Elmer V. Bernstam

• Univ. Texas Hlth. Sci. Ctr. Houston
• The University of Texas Health Science Center
• University of Texas Health Science Center
• Medical School, The University of Texas Health Science Center
• University of Texas School of Medicine at Houston
• University of Texas Health Science Center at Houston
• National Center for Cognitive Informatics and Decision Making
• The University of Texas Medical School at Houston
• 7000 Fannin St., Suite 600, H.
• University of Texas-Health Science Center at Houston
• The University of Texas Health Science Center at Houston
• the University of Texas Health Science Center
• University of Texas at Austin
• University of Texas MD Anderson Cancer Center
• Univ. Texas Hlth. Sci. Ctr. Houston
• Department of Internal Medicine
• School of Biomedical Informatics
• Department of Internal Medicine
• Department of General Internal Medicine
• Division of General Internal Medicine
• School of Biomedical Informatics
• Cardiology Division
• Center for Computational Biomedicine
• Div. of Allerg. and Clin. Immunology
• School of Health Information Sciences
• The University of Texas School of Health Information Sciences Houston
• Yale University
• School of Health Informatics
• Division of General Internal Medicine
• University of Texas System

External person

Spyros Triantos

• Janssen
• Johnson & Johnson
• LLC

External person

Robin Meng

• Genzyme Corporation
• Sanofi Research and Development

External person

Eskouhie Tchaparian

• Ltd.

External person

Tanvir Kaur

• All India Institute of Medical Sciences, New Delhi
• Indian Council of Medical Research

External person

Richard Carvajal

• Memorial Sloan-Kettering Cancer Center
• Columbia University
• Medical Center
• Melanoma Service
• Laboratory of New Drug Development
• Division of Hematology/Oncology
• University of Texas MD Anderson Cancer Center
• Sarcoma Service
• Department of Medicine
• Harvard University
• Department of Medical Oncology
• Clinical Genetics Service
• New York University
• Department of Medicine
• Division of Hematology/Oncology
• New York-Presbyterian/Columbia
• Northwell Health System

External person

Shu Yang

• Novartis

External person

L. Gao

• Eli Lilly

External person

Mark A. Ozog

• Zymeworks, Inc.

External person

Randal May

• University of Oklahoma
• Affairs Medical Center
• Department of Internal Medicine
• Department of Veterans
• Department of Medicine

External person

Satoshi Matsushima

• Fujifilm Corporation

External person

Yi Ju Chiang

• University of Texas MD Anderson Cancer Center
• Institute for Cancer Care Excellence
• Department of Surgical Oncology
• University of Texas Health Science Center at Houston

External person

Thorsten O. Goetze

• Krankenhaus Nordwest, Frankfurt am Main

External person

Chia Chi Lin

• National Taiwan University
• University of Texas Health Science Center at San Antonio
• Institute for Drug Development
• Division of Radiation Oncology
• Novartis Oncology
• Graduate Institute of Clinical Medicine
• Novartis

External person

Goura Kishor Rath

• Department of Radiation Oncology
• All India Institute of Medical Sciences, New Delhi
• Laboratory Oncology Unit
• Department of Radiation Oncology
• Department of Radiation Oncology
• All India Institute of Medical Sciences

External person

Huzhang Mao

• Eli Lilly

External person

Bumyang Kim

• University of Texas MD Anderson Cancer Center
• University of Texas Health Science Center at Houston
• Department of Health Services Research
• Department of Clinical Revenue and Reimbursement
• Section of Cancer Economics and Policy
• Health Services Research
• Section of Cancer Economics and Policy
• Milken Family Foundation

External person

Rona Yaeger

• Memorial Sloan-Kettering Cancer Center

External person

Mohamad Cherry

• The University of Oklahoma Stephenson Cancer Center
• Oklahoma University Health Sciences Center
• University of Oklahoma
• Department of Hematology and Oncology
• Section of Hematology-Oncology
• Department of Internal Medicine
• Department of Internal Medicine
• Section of Hematology-Oncology
• Department of Medicine
• Department of Hematology/Oncology
• Stephenson Cancer Center
• Department of Internal Medicine
• Department of Medicine
• Oklahoma City University

External person

Guangyu An

• Capital Medical University
• Department of Oncology
• Department of Oncology

External person

Igor Puzanov

• Department of Medicine
• Roswell Park Cancer Institute
• Vanderbilt University
• Department of Hematology and Oncology
• Department of Medicine
• CSC Building Roswell Park Cancer Institute
• Roswell Park Comprehensive Cancer Center
• Roswell Park Cancer Center
• Clovis Oncology
• SUNY Buffalo
• Roswell Park Comprehensive Cancer Center

External person

Navid Hafez

• Smilow Cancer Hospital
• Yale University
• Yale Cancer Center

External person

Huanyu Chen

• Ipsen

External person

Steven Bedrick

• Oregon Health and Science University
• Department of Medical Informatics and Clinical Epidemiology

External person

Jim Coward

External person

Elif Karatas

• University of Texas MD Anderson Cancer Center
• Yeshiva University
• Albert Einstein College of Medicine

External person

Yunfang Jiang

• University of Texas at Austin
• Univ. Tex. M.D. Anderson Cancer Ctr.
• U.T. MD Anderson Cancer Center
• University of Texas MD Anderson Cancer Center
• Department of Investigational Cancer Therapeutics (Phase I Program)
• Department of Lymphoma and Myeloma
• University of Texas Health Science Center at Houston

External person

Naveena B. Janakiram

• University of Oklahoma
• Department of Medicine

External person